Remote functionalization of SCH 39166: Discovery of potent and selective benzazepine dopamine D1 receptor antagonists

被引:6
|
作者
Sasikumar, T. K. [1 ]
Burnett, Duane A. [1 ]
Greenlee, William J. [1 ]
Smith, Michelle [1 ]
Fawzi, Ahmad [1 ]
Zhang, Hongtao [1 ]
Lachowicz, Jean E. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem & Metab Disorders, Kenilworth, NJ 07033 USA
关键词
SCH; 39166; Ecopipam; Benzazepine; Dopamine antagonist; Obesity; D1; SCH-39166; ANALOGS; BINDING; INVIVO;
D O I
10.1016/j.bmcl.2009.12.094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel benzazepine derived dopamine D-1 antagonists have been discovered. These compounds are highly potent at D1 and showed excellent selectivity over D-2 and D-4 receptors. SAR studies revealed that a variety of functional groups are tolerated on the D-ring of known tetracyclic benzazepine analog 2, SCH 39166, leading to compounds with nanomolar potency at D-1 and good selectivity over D-2-like receptors. Published by Elsevier Ltd.
引用
收藏
页码:832 / 835
页数:4
相关论文
共 50 条
  • [41] Discovery of LY3154207, a potent and selective dopamine receptor D1 positive allosteric modulator for the treatment of Parkinson's disease dementia
    Hao, Junliang
    Beck, James
    Krushinski, Joseph
    Schaus, John
    Wang, Xu-shan
    Heinz, Beverly
    Bruns, Robert
    Bender, David
    Cramer, Jeffery
    Svensson, Kjell
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [42] The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
    Millan, MJ
    Newman-Tancredi, A
    Quentric, Y
    Cussac, D
    PSYCHOPHARMACOLOGY, 2001, 156 (01) : 58 - 62
  • [43] The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
    Mark J. Millan
    Adrian Newman-Tancredi
    Yann Quentric
    Didier Cussac
    Psychopharmacology, 2001, 156 : 58 - 62
  • [44] CONFORMATIONAL-ANALYSIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF SELECTIVE DOPAMINE D-1 RECEPTOR AGONISTS AND ANTAGONISTS OF THE BENZAZEPINE SERIES
    PETTERSSON, I
    LILJEFORS, T
    BOGESO, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (08) : 2197 - 2204
  • [45] Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists
    Xiao, Jingbo
    Free, R. Benjamin
    Barnaeva, Elena
    Conroy, Jennie L.
    Doyle, Trevor
    Miller, Brittney
    Bryant-Genevier, Marthe
    Taylor, Mercedes K.
    Hu, Xin
    Dulcey, Andres E.
    Southall, Noel
    Ferrer, Marc
    Titus, Steve
    Zheng, Wei
    Sibley, David R.
    Marugan, Juan J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (08) : 3450 - 3463
  • [46] SYNTHESIS OF [C-11] SCH 23390 FOR DOPAMINE D1 RECEPTOR STUDIES
    DEJESUS, OT
    VANMOFFAERT, GJC
    FRIEDMAN, AM
    APPLIED RADIATION AND ISOTOPES, 1987, 38 (05) : 345 - 348
  • [47] Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists
    Morgan, BP
    Swick, AG
    Hargrove, DM
    LaFlamme, JA
    Moynihan, MS
    Carroll, RS
    Martin, KA
    Lee, E
    Decosta, D
    Bordner, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2417 - 2424
  • [48] Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines
    Neumeyer, JL
    Kula, NS
    Bergman, J
    Baldessarini, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 474 (2-3) : 137 - 140
  • [49] EVALUATION OF SCH-39166 AS PET LIGAND FOR CENTRAL D-1 DOPAMINE-RECEPTOR BINDING AND OCCUPANCY IN MAN
    KARLSSON, P
    SEDVALL, G
    HALLDIN, C
    SWAHN, CG
    FARDE, L
    PSYCHOPHARMACOLOGY, 1995, 121 (03) : 300 - 308
  • [50] EFFECTS OF THE DOPAMINE D-1 RECEPTOR ANTAGONIST SCH-39166 ON THE INGESTIVE BEHAVIOR OF ALCOHOL-PREFERRING RATS
    PANOCKA, I
    CICCOCIOPPO, R
    MOSCA, M
    POLIDORI, C
    MASSI, M
    PSYCHOPHARMACOLOGY, 1995, 120 (02) : 227 - 235